Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma
- 31 May 2009
- journal article
- review article
- Published by Elsevier BV in European Journal of Paediatric Neurology
- Vol. 13 (3), 219-223
- https://doi.org/10.1016/j.ejpn.2008.04.012
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Role of chemokines in tumor growthCancer Letters, 2007
- Rituximab (anti-CD20) Adjunctive Therapy for Opsoclonus-Myoclonus SyndromeJournal of Pediatric Hematology/Oncology, 2006
- Lymphoid neogenesis in chronic inflammatory diseasesNature Reviews Immunology, 2006
- Functional characterisation of autoantibodies from patients with pediatric opsoclonus–myoclonus-syndromeJournal of Neuroimmunology, 2005
- Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004Cancer Letters, 2005
- Paraneoplastic neurological degenerations: keys to tumour immunityNature Reviews Cancer, 2004
- Autoantigen diversity in the opsoclonus‐myoclonus syndromeAnnals of Neurology, 2003
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancerAnnals of Neurology, 1991
- Anti-neurofilament protein antibodies in opsoclonus-myoclonusJournal of Neuroimmunology, 1987